皮下利沃多巴:古老分子的新引擎
Karolina Poplawska-Domaszewicz1,2, Lucia Batzu3,4, Cristian Falup-Pecurariu4,5,6
1Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland. karolina.poplawska@usk.poznan.pl.
Neurology and therapy
|June 14, 2024
概括
新的皮下利沃多巴/糖比多巴输液为晚期帕金森病 (PD) 提供持续的药物输送,改善运动控制和减少休息时间. 这种非口服疗法在治疗复杂的PD症状方面表现有前途.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 管理面临着口服乐伏多巴的挑战,包括运动波动,运动障碍和非运动波动 (NMF).
- 先进的PD通常需要优化药物输送以保持治疗水平并改善生活质量.
研究的目的:
- 审查基于非口服乐伏多巴的持续药物递送 (CDD) 疗法对晚期帕金森病的不断变化的格局.
- 为了突出皮下利沃多巴/斯卡比多巴输注的疗效和临床可用性.
- 讨论其他新兴的非口服CDD选择以及它们在临床实践中的潜在整合.
主要方法:
- 对非口服利沃多巴基CDD系统的临床数据和文献的审查.
- 专注于皮下输注的福斯莱沃多巴/福斯卡比多巴,注射内输注的莱沃多巴-卡比多巴和莱沃多巴-卡-卡比多巴输注.
- 讨论诸如ND0612和DIZ102/DIZ101等药物的药理动力学/药理动力学,疗效和安全性概况.
主要成果:
- 皮下注射的利沃多巴/糖比多巴输液显示出显著的潜力,可以在没有麻烦的动力障碍的情况下增加"时间",并减少晚期PD的"休息时间".
- 这种疗法可以改善早晨的休息时间,睡眠质量以及运动和非运动症状.
- 新兴的非口服CDD选择显示出希望,但需要进一步的长期观察研究.
结论:
- 非口服的基于利沃多巴的CDD疗法,特别是皮下利沃多巴/斯卡比多巴,在治疗晚期帕金森病方面取得了重大进展.
- 这些疗法提供了一个务实的方法来解决口服乐伏多巴的局限性,改善症状控制和患者的结果.
- 需要进行进一步的长期研究,以充分了解这些新型疗法对现有的PD治疗模式的影响.
相关概念视频
01:24Parkinson's Disease: Treatment
255
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
255
01:22Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338
01:30Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
01:16Drug Delivery: Overview
285
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
285
01:29Drug Delivery: Parenteral Route
492
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
492
01:25Routes of Drug Administration: Parenteral
1.9K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
1.9K